Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Karenia, Landa"'
Autor:
Austin M. Eckhoff, Michael C. Brown, Karenia Landa, Ibtehaj Naqvi, Eda K. Holl, David Boczkowski, Ashley Fletcher, Kristen E. Rhodin, Minh Huy Giang, Bruce Sullenger, Georgia M. Beasley, Peter J. Allen, Smita K. Nair
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundMonocytes and monocyte-derived tumor infiltrating cells have been implicated in the immunosuppression and immune evasion associated with pancreatic adenocarcinoma (PDAC). Yet, precisely how monocytes in the periphery and tumor microenvironm
Externí odkaz:
https://doaj.org/article/1eb497b660224ba3b823ad6d334a8bd8
Autor:
Elias O.U. Eteshola, Karenia Landa, Rachel E. Rempel, Ibtehaj A. Naqvi, E. Shelley Hwang, Smita K. Nair, Bruce A. Sullenger
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 26, Iss , Pp 1-10 (2021)
Breast cancer (BC) is the most common malignancy in women. Particular subtypes with aggressive behavior are major contributors to poor outcomes. Triple-negative breast cancer (TNBC) is difficult to treat, pro-inflammatory, and highly metastatic. We d
Externí odkaz:
https://doaj.org/article/525370bc8ac34046ab73baf6e327f0e5
Autor:
Matthias Gromeier, Darell D Bigner, Smita K Nair, David Boczkowski, Michael C Brown, Karenia Landa, Sin-Ho Jung, Georgia M Beasley, Norma E Farrow, Maria Angelica Selim, Rami N Al-Rohil, Aaron D Therien, Junheng Gao, Eda K Holl
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 9 (2022)
Background We previously reported results from a phase 1 study testing intratumoral recombinant poliovirus, lerapolturev, in 12 melanoma patients. All 12 patients received anti-PD-1 systemic therapy before lerapolturev, and 11 of these 12 patients al
Externí odkaz:
https://doaj.org/article/04605eb95ab14089a2829c1d83ca4646
Autor:
Matthias Gromeier, Darell D Bigner, Smita K Nair, Karenia Landa, Sin-Ho Jung, Georgia M Beasley, Norma E Farrow, Maria Angelica Selim, Carol Ann Wiggs, Andrea True Kelly, April KS Salama
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 4 (2021)
Background While programmed cell death protein 1 (PD-1) and programmed death-ligand 1 (PD-L1) antagonists have improved the prognosis for many patients with melanoma, around 60% fail therapy. PVSRIPO is a non-neurovirulent rhinovirus:poliovirus chime
Externí odkaz:
https://doaj.org/article/e28cb6ceb21645b987a84e695f9c4187
Autor:
Matthias Gromeier, Georgia Beasley, Nellie Farrow, Karenia Landa, Maria Angelica Seilm, Sin-Ho Jung, Darell Bigner, Andrea True Kelly, Smita Nair, April Salama
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/ac194a89524846a5988f8389cddbee1c
Autor:
Adrienne B. Shannon, Richard J. Straker, Michael J. Carr, James Sun, Karenia Landa, Kirsten Baecher, Kevin Lynch, Harrison G. Bartels, Robyn Panchaud, Luke J. Keele, Michael C. Lowe, Craig L. Slingluff, Mark J. Jameson, Kenneth Y. Tsai, Mark B. Faries, Georgia M. Beasley, Vernon K. Sondak, Giorgos C. Karakousis, Jonathan S. Zager, John T. Miura
Publikováno v:
Annals of Surgical Oncology. 29:7033-7044
Autor:
Austin M. Eckhoff, Ashley A. Fletcher, Karenia Landa, Matthew Iyer, Daniel P. Nussbaum, Chanjuan Shi, Smita K. Nair, Peter J. Allen
Publikováno v:
Annals of Surgical Oncology. 29:7781-7788
Autor:
Eda K. Holl, Victoria N. Frazier, Karenia Landa, Georgia M. Beasley, E. Shelley Hwang, Smita K. Nair
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Immunotherapies are rapidly being integrated into standard of care (SOC) therapy in conjunction with surgery, chemotherapy, and radiotherapy for many cancers and a large number of clinical studies continue to explore immunotherapy alone and as part o
Externí odkaz:
https://doaj.org/article/613a7b1934524f4ba8ae1649397d30e1
Autor:
Bruce A. Sullenger, E. Shelley Hwang, Ibtehaj A. Naqvi, Rachel E. Rempel, Elias O.U. Eteshola, Karenia Landa, Smita K. Nair
Publikováno v:
Molecular Therapy. Nucleic Acids
Molecular Therapy: Nucleic Acids, Vol 26, Iss, Pp 1-10 (2021)
Molecular Therapy: Nucleic Acids, Vol 26, Iss, Pp 1-10 (2021)
Breast cancer (BC) is the most common malignancy in women. Particular subtypes with aggressive behavior are major contributors to poor outcomes. Triple-negative breast cancer (TNBC) is difficult to treat, pro-inflammatory, and highly metastatic. We d
Autor:
Karenia Landa, Theodore N. Pappas
Publikováno v:
Annals of surgery.